Overview of current melanoma therapies
Pigment Cell Melanoma Res. 2023 Dec 8. doi: 10.1111/pcmr.13154. Online ahead of print.ABSTRACTMelanoma is the most aggressive type of skin cancer and is responsible for the majority of deaths from skin cancer. Therapeutic advances in the last few decades, notably the development of novel targeted therapies and immunotherapies have significantly improved patient outcomes; nonetheless, these options remain limited due to the onset of resistance to treatment modalities and relapse. In this review, we focus on the available therapeutic options, their benefits, and limitations.PMID:38063139 | DOI:10.1111/pcmr.13154 (Source: Pig...
Source: Pigment Cell and Melanoma Research - December 8, 2023 Category: Cytology Authors: Anna Fateeva Kevinn Eddy Suzie Chen Source Type: research
Overview of current melanoma therapies
Pigment Cell Melanoma Res. 2023 Dec 8. doi: 10.1111/pcmr.13154. Online ahead of print.ABSTRACTMelanoma is the most aggressive type of skin cancer and is responsible for the majority of deaths from skin cancer. Therapeutic advances in the last few decades, notably the development of novel targeted therapies and immunotherapies have significantly improved patient outcomes; nonetheless, these options remain limited due to the onset of resistance to treatment modalities and relapse. In this review, we focus on the available therapeutic options, their benefits, and limitations.PMID:38063139 | DOI:10.1111/pcmr.13154 (Source: Pig...
Source: Pigment Cell and Melanoma Research - December 8, 2023 Category: Cytology Authors: Anna Fateeva Kevinn Eddy Suzie Chen Source Type: research
Overview of current melanoma therapies
Pigment Cell Melanoma Res. 2023 Dec 8. doi: 10.1111/pcmr.13154. Online ahead of print.ABSTRACTMelanoma is the most aggressive type of skin cancer and is responsible for the majority of deaths from skin cancer. Therapeutic advances in the last few decades, notably the development of novel targeted therapies and immunotherapies have significantly improved patient outcomes; nonetheless, these options remain limited due to the onset of resistance to treatment modalities and relapse. In this review, we focus on the available therapeutic options, their benefits, and limitations.PMID:38063139 | DOI:10.1111/pcmr.13154 (Source: Pig...
Source: Pigment Cell and Melanoma Research - December 8, 2023 Category: Cytology Authors: Anna Fateeva Kevinn Eddy Suzie Chen Source Type: research
Overview of current melanoma therapies
Pigment Cell Melanoma Res. 2023 Dec 8. doi: 10.1111/pcmr.13154. Online ahead of print.ABSTRACTMelanoma is the most aggressive type of skin cancer and is responsible for the majority of deaths from skin cancer. Therapeutic advances in the last few decades, notably the development of novel targeted therapies and immunotherapies have significantly improved patient outcomes; nonetheless, these options remain limited due to the onset of resistance to treatment modalities and relapse. In this review, we focus on the available therapeutic options, their benefits, and limitations.PMID:38063139 | DOI:10.1111/pcmr.13154 (Source: Pig...
Source: Pigment Cell and Melanoma Research - December 8, 2023 Category: Cytology Authors: Anna Fateeva Kevinn Eddy Suzie Chen Source Type: research
Overview of current melanoma therapies
Pigment Cell Melanoma Res. 2023 Dec 8. doi: 10.1111/pcmr.13154. Online ahead of print.ABSTRACTMelanoma is the most aggressive type of skin cancer and is responsible for the majority of deaths from skin cancer. Therapeutic advances in the last few decades, notably the development of novel targeted therapies and immunotherapies have significantly improved patient outcomes; nonetheless, these options remain limited due to the onset of resistance to treatment modalities and relapse. In this review, we focus on the available therapeutic options, their benefits, and limitations.PMID:38063139 | DOI:10.1111/pcmr.13154 (Source: Pig...
Source: Pigment Cell and Melanoma Research - December 8, 2023 Category: Cytology Authors: Anna Fateeva Kevinn Eddy Suzie Chen Source Type: research
Overview of current melanoma therapies
Pigment Cell Melanoma Res. 2023 Dec 8. doi: 10.1111/pcmr.13154. Online ahead of print.ABSTRACTMelanoma is the most aggressive type of skin cancer and is responsible for the majority of deaths from skin cancer. Therapeutic advances in the last few decades, notably the development of novel targeted therapies and immunotherapies have significantly improved patient outcomes; nonetheless, these options remain limited due to the onset of resistance to treatment modalities and relapse. In this review, we focus on the available therapeutic options, their benefits, and limitations.PMID:38063139 | DOI:10.1111/pcmr.13154 (Source: Pig...
Source: Pigment Cell and Melanoma Research - December 8, 2023 Category: Cytology Authors: Anna Fateeva Kevinn Eddy Suzie Chen Source Type: research
Overview of current melanoma therapies
Pigment Cell Melanoma Res. 2023 Dec 8. doi: 10.1111/pcmr.13154. Online ahead of print.ABSTRACTMelanoma is the most aggressive type of skin cancer and is responsible for the majority of deaths from skin cancer. Therapeutic advances in the last few decades, notably the development of novel targeted therapies and immunotherapies have significantly improved patient outcomes; nonetheless, these options remain limited due to the onset of resistance to treatment modalities and relapse. In this review, we focus on the available therapeutic options, their benefits, and limitations.PMID:38063139 | DOI:10.1111/pcmr.13154 (Source: Pig...
Source: Pigment Cell and Melanoma Research - December 8, 2023 Category: Cytology Authors: Anna Fateeva Kevinn Eddy Suzie Chen Source Type: research
Overview of current melanoma therapies
Pigment Cell Melanoma Res. 2023 Dec 8. doi: 10.1111/pcmr.13154. Online ahead of print.ABSTRACTMelanoma is the most aggressive type of skin cancer and is responsible for the majority of deaths from skin cancer. Therapeutic advances in the last few decades, notably the development of novel targeted therapies and immunotherapies have significantly improved patient outcomes; nonetheless, these options remain limited due to the onset of resistance to treatment modalities and relapse. In this review, we focus on the available therapeutic options, their benefits, and limitations.PMID:38063139 | DOI:10.1111/pcmr.13154 (Source: Pig...
Source: Pigment Cell and Melanoma Research - December 8, 2023 Category: Cytology Authors: Anna Fateeva Kevinn Eddy Suzie Chen Source Type: research
Overview of current melanoma therapies
Pigment Cell Melanoma Res. 2023 Dec 8. doi: 10.1111/pcmr.13154. Online ahead of print.ABSTRACTMelanoma is the most aggressive type of skin cancer and is responsible for the majority of deaths from skin cancer. Therapeutic advances in the last few decades, notably the development of novel targeted therapies and immunotherapies have significantly improved patient outcomes; nonetheless, these options remain limited due to the onset of resistance to treatment modalities and relapse. In this review, we focus on the available therapeutic options, their benefits, and limitations.PMID:38063139 | DOI:10.1111/pcmr.13154 (Source: Pig...
Source: Pigment Cell and Melanoma Research - December 8, 2023 Category: Cytology Authors: Anna Fateeva Kevinn Eddy Suzie Chen Source Type: research
Risk factors for sentinel lymph node metastasis in Korean acral and non-acral melanoma patients
Pigment Cell Melanoma Res. 2023 Nov 27. doi: 10.1111/pcmr.13153. Online ahead of print.ABSTRACTBreslow thickness, ulceration, and mitotic rate are well-known prognostic factors for sentinel lymph node (SLN) metastasis in cutaneous melanoma. We investigated risk factors, including especially the degree of pigmentation, for SLN metastasis in Korean melanoma patients. We enrolled 158, composed of Korean 107 acral and 51 non-acral melanoma patients who underwent SLN biopsy. Clinicopathologic features such as Breslow thickness, ulceration, mitotic rate, and the degree of pigmentation were evaluated. The recurrence-free survival...
Source: Pigment Cell and Melanoma Research - November 28, 2023 Category: Cytology Authors: Jee Yong Song Young Jae Ryu Ho Kyun Lee Dong Hoon Lee Yoo Duk Choi Hyun Jeong Shim Sook Jung Yun Source Type: research
Risk factors for sentinel lymph node metastasis in Korean acral and non-acral melanoma patients
Pigment Cell Melanoma Res. 2023 Nov 27. doi: 10.1111/pcmr.13153. Online ahead of print.ABSTRACTBreslow thickness, ulceration, and mitotic rate are well-known prognostic factors for sentinel lymph node (SLN) metastasis in cutaneous melanoma. We investigated risk factors, including especially the degree of pigmentation, for SLN metastasis in Korean melanoma patients. We enrolled 158, composed of Korean 107 acral and 51 non-acral melanoma patients who underwent SLN biopsy. Clinicopathologic features such as Breslow thickness, ulceration, mitotic rate, and the degree of pigmentation were evaluated. The recurrence-free survival...
Source: Pigment Cell and Melanoma Research - November 28, 2023 Category: Cytology Authors: Jee Yong Song Young Jae Ryu Ho Kyun Lee Dong Hoon Lee Yoo Duk Choi Hyun Jeong Shim Sook Jung Yun Source Type: research
Risk factors for sentinel lymph node metastasis in Korean acral and non-acral melanoma patients
Pigment Cell Melanoma Res. 2023 Nov 27. doi: 10.1111/pcmr.13153. Online ahead of print.ABSTRACTBreslow thickness, ulceration, and mitotic rate are well-known prognostic factors for sentinel lymph node (SLN) metastasis in cutaneous melanoma. We investigated risk factors, including especially the degree of pigmentation, for SLN metastasis in Korean melanoma patients. We enrolled 158, composed of Korean 107 acral and 51 non-acral melanoma patients who underwent SLN biopsy. Clinicopathologic features such as Breslow thickness, ulceration, mitotic rate, and the degree of pigmentation were evaluated. The recurrence-free survival...
Source: Pigment Cell and Melanoma Research - November 28, 2023 Category: Cytology Authors: Jee Yong Song Young Jae Ryu Ho Kyun Lee Dong Hoon Lee Yoo Duk Choi Hyun Jeong Shim Sook Jung Yun Source Type: research
Risk factors for sentinel lymph node metastasis in Korean acral and non-acral melanoma patients
Pigment Cell Melanoma Res. 2023 Nov 27. doi: 10.1111/pcmr.13153. Online ahead of print.ABSTRACTBreslow thickness, ulceration, and mitotic rate are well-known prognostic factors for sentinel lymph node (SLN) metastasis in cutaneous melanoma. We investigated risk factors, including especially the degree of pigmentation, for SLN metastasis in Korean melanoma patients. We enrolled 158, composed of Korean 107 acral and 51 non-acral melanoma patients who underwent SLN biopsy. Clinicopathologic features such as Breslow thickness, ulceration, mitotic rate, and the degree of pigmentation were evaluated. The recurrence-free survival...
Source: Pigment Cell and Melanoma Research - November 28, 2023 Category: Cytology Authors: Jee Yong Song Young Jae Ryu Ho Kyun Lee Dong Hoon Lee Yoo Duk Choi Hyun Jeong Shim Sook Jung Yun Source Type: research
Risk factors for sentinel lymph node metastasis in Korean acral and non-acral melanoma patients
Pigment Cell Melanoma Res. 2023 Nov 27. doi: 10.1111/pcmr.13153. Online ahead of print.ABSTRACTBreslow thickness, ulceration, and mitotic rate are well-known prognostic factors for sentinel lymph node (SLN) metastasis in cutaneous melanoma. We investigated risk factors, including especially the degree of pigmentation, for SLN metastasis in Korean melanoma patients. We enrolled 158, composed of Korean 107 acral and 51 non-acral melanoma patients who underwent SLN biopsy. Clinicopathologic features such as Breslow thickness, ulceration, mitotic rate, and the degree of pigmentation were evaluated. The recurrence-free survival...
Source: Pigment Cell and Melanoma Research - November 28, 2023 Category: Cytology Authors: Jee Yong Song Young Jae Ryu Ho Kyun Lee Dong Hoon Lee Yoo Duk Choi Hyun Jeong Shim Sook Jung Yun Source Type: research
Risk factors for sentinel lymph node metastasis in Korean acral and non-acral melanoma patients
Pigment Cell Melanoma Res. 2023 Nov 27. doi: 10.1111/pcmr.13153. Online ahead of print.ABSTRACTBreslow thickness, ulceration, and mitotic rate are well-known prognostic factors for sentinel lymph node (SLN) metastasis in cutaneous melanoma. We investigated risk factors, including especially the degree of pigmentation, for SLN metastasis in Korean melanoma patients. We enrolled 158, composed of Korean 107 acral and 51 non-acral melanoma patients who underwent SLN biopsy. Clinicopathologic features such as Breslow thickness, ulceration, mitotic rate, and the degree of pigmentation were evaluated. The recurrence-free survival...
Source: Pigment Cell and Melanoma Research - November 28, 2023 Category: Cytology Authors: Jee Yong Song Young Jae Ryu Ho Kyun Lee Dong Hoon Lee Yoo Duk Choi Hyun Jeong Shim Sook Jung Yun Source Type: research
